Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Sensex Opens 240 Points Lower; Metal & PSU Stocks Drag
Mon, 13 Aug 09:30 am | Rini Mehta, TM Team

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 1.7% while the Hang Seng is down 1.8%. The Nikkei 225 is trading down by 1.6%. US stocks slid on Friday as a deepening economic crisis in Turkey dragged on bank shares and triggered a move out of riskier assets.

Back home, India share markets have opened the day on a lower note. The BSE Sensex is trading down by 239 points while the NSE Nifty is trading down by 80 points. The BSE Mid Cap index opened and BSE Small Cap index opened the day down by 0.9% & 0.7% respectively.

The rupee is currently trading at 68.95 to the US$.

Sectoral indices have opened the in on a mixed note with information technology stocks and healthcare stocks witnessing maximum buying interest. While, metal stocks and PSU stocks have opened the day in red.

In the news from the pharma sector. As per an article in a leading financial daily, Cipla has received final approval for its abbreviated new drug application (ANDA) for Atazanavir Caps 100mg, 150mg, 200mg, and 300mg from the United States Food and Drug Administration (USFDA).

According to IQVIA (IMS Health), Reyataz and its generic equivalents had US sales of approximately US$324mn for the 12-month period ending April 2018.

--- Advertisement ---
Claim Your Virtually Free Book Before We Run Out of Stock - 1,000 Copies Only

Our 220-page book, Equitymaster's Secrets: The Biggest Lessons From our Entire 20+ Years Investing Journey is available on Amazon for Rs 1,450.

But recently, we decided to publish an updated edition - with a special message on investing from Tanushree Banerjee.

And today, as a special thank you to loyal readers like you, we've decided to give away 1,000 copies of this Limited Edition hardbound book - virtually free.

But there's a catch: We can only send this book to an Indian address.

Reserve your copy by providing your Indian postal address here.

Cipla's Atazanavir Caps 100mg, 150mg, 200mg, and 300mg are an AB-rated generic therapeutic equivalent version of Bristol-Myers Squibb Pharma Company's, Reyataz.

It is a protease inhibitor indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in patients aged 6 years and older and weighing at least 15 kg.

Cipla share price opened the day up by 0.6%.

Speaking of the pharma sector, the BSE Healthcare Index has been on a roller coaster ride in the past few years. The period from 2012 to 2015 saw the index go up more than three times.

The Roller Coaster Ride of the BSE Healthcare Index

Since then it has been a painful ride downwards.

Pre-2015, pharma companies enjoyed a fairytale ride in the US market. Low labor costs, good chemistry skills, along with efficiency, ensured Indian companies could copy innovator drugs to make generic drugs at a fast pace.

The generic business had lucrative margins for all major pharma players. But the party did not last long. In the quest to supply drugs quickly, they compromised on quality at their manufacturing facilities.

The regulatory issues coupled with price erosion in US markets has impacted the business of major pharma players.

Moving on to the news from the economy. In the latest development, India's factory output grew at its fastest pace in five months at 7% in June on the back of a lower base last year due to destocking by businesses ahead of introduction of the Goods and Services Tax (GST).

The radical indirect tax reform was introduced on 1 July 2017 and disruptions continued till October. This may provide a favourable base for higher growth in the index of industrial production (IIP) in coming months.

Consumer goods, which was the worst affected sector in the run up to the introduction of GST, grew at a 21-month high of 13.1% in June. While capital goods maintained a positive growth rate at 9.6% during the month.

However, consumer non-durables continued their dismal performance, growing at 0.5% in June, reflecting poor rural demand conditions. This is expected to change with the India Meteorological Department (IMD) last week predicting favourable distribution of rainfall during August and September, the reports noted.

As per India Ratings and Research, while primary goods, one of the lead indicators of industrial growth, is exhibiting good growth and gives confidence of sustained industrial recovery, intermediate goods do not give much confidence on sustainability of the recovery.

Note that, RBI's monetary policy committee raised policy rates by 25 basis points to 6.5% earlier this month. This is the first time since October 2013 that RBI has raised rates in consecutive meetings of its rate-setting panel.

However, at Equitymaster, we do not attempt to predict how and when macroeconomic developments will unfold. Instead, we focus on the fundamentals and the underlying business strength of companies.

The ValuePro team is always on the lookout for all-weather stocks whose fortunes are not tied to economic cycles.

By the way, in the latest edition of our stock market podcast, I talk to Tanushree Banerjee, Co-head of Research, about investing in volatile markets like these. Have a question for Tanushree? Write in. Don't miss it! Sign up for our free podcast today. Visit SoundCloud, iTunes or Stitcher.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Sensex Opens 240 Points Lower; Metal & PSU Stocks Drag". Click here!


Stock Market Updates

Sensex Ends Marginally Higher; Telecom and Oil & Gas Stocks Witness Buying (Today's Market)

Dec 14, 2018 Closing

While the BSE Sensex closed higher by 33 points, NSE Nifty closed higher by 14 points

Most Active Small-Cap Stocks Today; PC JEWELLER the Most Traded (Today's Market)

Dec 14, 2018 03:53 PM

Here's a list of most active small-cap stocks today. It also includes information on BSE Smallcap index and the broader benchmark indices.

Top 5 Mid-Cap Gainers Today; SUPREME INDUSTRIES Leads the Pack (Today's Market)

Dec 14, 2018 03:52 PM

Here's a list of 5 stocks that gained the most in the BSE Mid-Cap Index today. It also includes information on BSE Mid-Cap index and the broader benchmark indices.

SYNGENE INTERNATIONAL Surges by 5%; BSE HEALTHCARE Index Down 0.8% (Today's Market)

Dec 14, 2018 03:33 PM

SYNGENE INTERNATIONAL share price has surged by 5% and its current market price is Rs 582. The BSE HEALTHCARE is down by 0.8%. The top gainers in the BSE HEALTHCARE Index is SYNGENE INTERNATIONAL (up 5.4%). The top losers are LUPIN LTD (down 0.1%) and IPCA LABS (down 0.2%).

VARUN BEVERAGES LTD Plunges by 6%; BSE 500 Index Down 0.1% (Today's Market)

Dec 14, 2018 02:33 PM

VARUN BEVERAGES LTD share price has plunged by 6% and its current market price is Rs 734. The BSE 500 is down by 0.1%. The top gainers in the BSE 500 Index are RELIANCE NAVAL & ENGINEERING LTD (up 14.0%) and GUJARAT GAS LTD (up 5.4%). The top losers are VARUN BEVERAGES LTD (down 5.6%) and FORTIS HEALTHCARE (down 7.7%).

Sensex Trades Flat; Bharti Airtel & Yes Bank Top Gainers (Today's Market)

Dec 14, 2018 12:30 pm

The BSE Sensex is trading up by 35 points, while the NSE Nifty is trading up by 5 points.

View More Indian Share Market News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

Are Foreign Investors Heading Back to the Indian Stock Markets?(Chart Of The Day)

Dec 3, 2018

After months of heavy FII selling, November witnessed a return on foreign money into Indian equities...

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.


Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Dec 14, 2018 (Close)